"Advanced sarcoma" trang 1 - tải miễn phí từ tailieunhanh
Long-term outcome and effect of maintenance therapy in patients with advanced sarcoma treated with trabectedin: An analysis of 181 patients of the French ATU compassionate use program

Long-term outcome and effect of maintenance therapy in patients with advanced sarcoma treated with trabectedin: An analysis of 181 patients of the French ATU compassionate use program
8    63    1
Apatinib for advanced sarcoma: Results from multiple institutions’ off-label use in China

Apatinib for advanced sarcoma: Results from multiple institutions’ off-label use in China
10    60    1
Combination therapy with Olaratumab/ doxorubicin in advanced or metastatic soft tissue sarcoma - a single-Centre experience

Combination therapy with Olaratumab/ doxorubicin in advanced or metastatic soft tissue sarcoma - a single-Centre experience
8    56    1
A phase II study of gemcitabine and docetaxel combination in relapsed metastatic or unresectable locally advanced synovial sarcoma

A phase II study of gemcitabine and docetaxel combination in relapsed metastatic or unresectable locally advanced synovial sarcoma
10    1    1
Radiotherapy in bone sarcoma: The quest for better treatment option

Radiotherapy in bone sarcoma: The quest for better treatment option
21    1    1
Safety and efficacy of Pazopanib in advanced soft tissue sarcoma: PALETTE (EORTC 62072) subgroup analyses

Safety and efficacy of Pazopanib in advanced soft tissue sarcoma: PALETTE (EORTC 62072) subgroup analyses
7    66    0
Surrogacy of intermediate endpoints for overall survival in randomized controlled trials of first-line treatment for advanced soft tissue sarcoma in the pre- and postpazopanib era: A meta-analytic evaluation

Surrogacy of intermediate endpoints for overall survival in randomized controlled trials of first-line treatment for advanced soft tissue sarcoma in the pre- and postpazopanib era: A meta-analytic evaluation
9    62    2
Protocol for the 2ND-STEP study, Japan Clinical Oncology Group study JCOG1802: A randomized phase II trial of second-line treatment for advanced soft tissue sarcoma comparing trabectedin, eribulin and pazopanib

Protocol for the 2ND-STEP study, Japan Clinical Oncology Group study JCOG1802: A randomized phase II trial of second-line treatment for advanced soft tissue sarcoma comparing trabectedin, eribulin and pazopanib
8    4    1
Risk factors for pneumothorax in advanced and/or metastatic soft tissue sarcoma patients during pazopanib treatment: A single-institute analysis

Risk factors for pneumothorax in advanced and/or metastatic soft tissue sarcoma patients during pazopanib treatment: A single-institute analysis
7    32    1
Efficacy and safety of pharmacological interventions in second- or later-line treatment of patients with advanced soft tissue sarcoma: A systematic review

Efficacy and safety of pharmacological interventions in second- or later-line treatment of patients with advanced soft tissue sarcoma: A systematic review
21    26    1
Results of a phase I dose escalation study of eltrombopag in patients with advanced soft tissue sarcoma receiving doxorubicin and ifosfamide

Results of a phase I dose escalation study of eltrombopag in patients with advanced soft tissue sarcoma receiving doxorubicin and ifosfamide
9    35    1
Clinical markers of immunotherapy outcomes in advanced sarcoma

Clinical markers of immunotherapy outcomes in advanced sarcoma
8    4    1
báo cáo hóa học:

báo cáo hóa học:" AIDS-associated Kaposi’s sarcoma is linked to advanced disease and high mortality in a primary care HIV programme in South Africa"
5    48    0
Activity of PD1 inhibitor therapy in advanced sarcoma: A single-center retrospective analysis

Activity of PD1 inhibitor therapy in advanced sarcoma: A single-center retrospective analysis
11    92    1
Study protocol of REGOSARC trial: Activity and safety of regorafenib in advanced soft tissue sarcoma: a multinational, randomized, placebo-controlled, phase II trial

Study protocol of REGOSARC trial: Activity and safety of regorafenib in advanced soft tissue sarcoma: a multinational, randomized, placebo-controlled, phase II trial
10    70    1